Tazopime 1000mg/125mg Injection
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Tazopime 1000mg/125mg Injection
This dual-antibiotic injection, Tazopime 1000 mg/125 mg, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a healthcare provider; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions like redness, swelling, and pain may also occur but usually resolve spontaneously. Worsening side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all current medications, and pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs.
Uses of Tazopime 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Tazopime 1000mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Tazopime 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Tazopime 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Tazopime 1000mg/125mg Injection works:
Tazopime, a 1000 mg/125 mg injectable formulation, unites the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial enzymes (beta-lactamases) that would otherwise neutralize cefepime. This synergistic action broadens cefepime's effectiveness by overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Tazopime 1000 mg/125 mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Tazopime 1000 mg/125 mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely administer Tazopime 1000 mg/125 mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Tazopime 1000 mg/125 mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
For individuals with impaired kidney function, administration of Tazopime 1000 mg/125 mg Injection requires careful monitoring. Dosage modification of Tazopime 1000 mg/125 mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Individuals with hepatic impairment may likely tolerate Tazopime 1000 mg/125 mg Injection without requiring dosage modification, based on currently available, albeit limited, evidence. Physician consultation is recommended.
What if you forget to take Tazopime 1000mg/125mg Injection :
Omitting a scheduled dose of Tazopime 1000 mg/125 mg Injection necessitates contacting your physician.
Facts to Know About Tazopime 1000mg/125mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Drugs to fight infection |
3,018 People bought this recently